Yahoo Web Search

Search results

    • FDA clears GSK's RSV vaccine for adults ages 50-59

      FDA clears GSK's RSV vaccine for adults ages 50-59

      United Press International via Yahoo News· 7 hours ago

      The U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...

    • Letters to the Editor for June 8, 2024

      Letters to the Editor for June 8, 2024

      Waterloo-Cedar Falls Courier· 19 hours ago

      The reaction of the Republican leadership in Iowa and Washington regarding the recent trial and verdict impacting Donald Trump speaks volumes about their...